CTNNA3, associated with the risk of late-onset AD and plasma Aβ levels (Miyashita et al. 2007; Lincoln et al. 2013), is an upregulated gene in glial cells, ExN, and InN in aging TS (supplementary fig. The gene discussed is GHRH; the disease is Alzheimer disease.